(Q38504462)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17873846%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

title

Synthesis of sulfonamides and evaluation of their histone deacetylase (HDAC) activity (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17873846%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

author name string

Seikwan Oh

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17873846%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Hyung-In Moon

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17873846%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Il-Hong Son

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17873846%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Jae-Chul Jung

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17873846%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Mitchell A Avery

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17873846%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

language of work or name

English

0 references

publication date

24 May 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17873846%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17873846%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17873846%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17873846%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

page(s)

1125-1135

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17873846%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

7 January 2020

copyright license

start time

24 May 2007

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Discovery of pyrimidyl-5-hydroxamic acids as new potent histone deacetylase inhibitors.

1 reference

Crossref

https://api.crossref.org/works/10.3390%2F12051125

Development of potential antitumor agents. Synthesis and biological evaluation of a new set of sulfonamide derivatives as histone deacetylase inhibitors

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.3390%2F12051125

Cell cycle regulation in the G1 phase: a promising target for the development of new chemotherapeutic anticancer agents

21 January 2018

1 reference

12 December 2020

Targeted histone deacetylase inhibition for cancer therapy

1 reference

12 December 2020

Design, synthesis, and evaluation of cyclic amide/imide-bearing hydroxamic acid derivatives as class-selective histone deacetylase (HDAC) inhibitors

1 reference

12 December 2020

Synthesis, enzymatic inhibition, and cancer cell growth inhibition of novel delta-lactam-based histone deacetylase (HDAC) inhibitors

1 reference

12 December 2020

Sulfonamide anilides, a novel class of histone deacetylase inhibitors, are antiproliferative against human tumors

1 reference

12 December 2020

Histone deacetylase inhibitors suppress the inducibility of nuclear factor-kappaB by tumor necrosis factor-alpha receptor-1 down-regulation

1 reference

12 December 2020

Histone deacetylation in epigenetics: an attractive target for anticancer therapy

1 reference

12 December 2020

Clinical experience with intravenous and oral formulations of the novel histone deacetylase inhibitor suberoylanilide hydroxamic acid in patients with advanced hematologic malignancies

1 reference

12 December 2020

Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A

1 reference

12 December 2020

Novel inhibitors of human histone deacetylases: design, synthesis, enzyme inhibition, and cancer cell growth inhibition of SAHA-based non-hydroxamates.

1 reference

12 December 2020

Novel Hydroxamate and Anilide Derivatives as Potent Histone Deacetylase Inhibitors: Synthesis and Antiproliferative Evaluation

1 reference

12 December 2020

Convenient synthesis of L-proline benzyl ester

1 reference

12 December 2020

Histone deacetylase inhibitors in cancer treatment

1 reference

12 December 2020

Differential expression of class I HDACs: roles of cell density and cell cycle.

1 reference

12 December 2020

Novel histone deacetylase inhibitors: N-hydroxycarboxamides possessing a terminal bicyclic aryl group

1 reference

12 December 2020

Design and synthesis of a novel class of histone deacetylase inhibitors

1 reference

12 December 2020

Amino acids and peptides. LII. Design and synthesis of opioid mimetics containing a pyrazinone ring and examination of their opioid receptor binding activity

1 reference

12 December 2020

Ineffectiveness of histone deacetylase inhibitors to induce apoptosis involves the transcriptional activation of NF-kappa B through the Akt pathway

1 reference

12 December 2020

Identifiers

DOI

10.3390/12051125

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17873846%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17873846%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

PubMed publication ID

17873846

1 reference